This paper is in the following e-collection/theme issue:

#xInfectiousDiseases (28) JMIR Theme Issue: COVID-19 Special Issue (2458) #xPublicandGlobalHealth (34)

Published on in Vol 2, No 3 (2021): Jul-Sep

Preprints (earlier versions) of this paper are available at https://www.medrxiv.org/content/10.1101/2021.04.09.21255219v1, first published .
Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study

Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study

Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study

Authors of this article:

Mark Jarrett1 Author Orcid Image ;   Warren Licht1 Author Orcid Image ;   Kevin Bock1 Author Orcid Image ;   Zenobia Brown1 Author Orcid Image ;   Jamie Hirsch1 Author Orcid Image ;   Kevin Coppa2 Author Orcid Image ;   Rajdeep Brar1 Author Orcid Image ;   Stephen Bello2 Author Orcid Image ;   Ira Nash1 Author Orcid Image
Article Authors Cited by (4) Tweetations (4) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.